- Home
- AUTL vs QSI Comparison
AUTL vs QSI Comparison
Compare AUTL & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | QSI |
|---|---|---|
| Founded | 2014 | 2013 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 273.7M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUTL | QSI |
|---|---|---|
| Price | $1.95 | $1.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $8.67 | $2.63 |
| AVG Volume (30 Days) | 2.7M | ★ 5.2M |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $51,128,000.00 | $3,177,000.00 |
| Revenue This Year | $669.49 | N/A |
| Revenue Next Year | $91.53 | $159.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 406.67 | 40.20 |
| 52 Week Low | $1.11 | $0.95 |
| 52 Week High | $2.70 | $4.63 |
Technical Indicators
Market Signals| Indicator | AUTL | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 64.20 | 47.86 |
| Support Level | $1.77 | $1.07 |
| Resistance Level | $2.05 | $1.34 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.02 | 0.02 |
| Stochastic Oscillator | 75.73 | 74.07 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.